Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety

Vista sencilla de ítem
dc.contributor.authorOrtiz Ramírez, Mario Isidoroen_US
dc.date.accessioned2013-11-05T22:00:09Z
dc.date.available2013-11-05T22:00:09Z
dc.date.issued2008en_US
dc.description.abstractAcemetacin is a non-steroidal anti-inflammatory drug which is rapidly bioconverted to indomethacin, but produces significantly less gastric damage than indomethacin. This study was performed to investigate several possible mechanisms that could account for the gastrointestinal tolerability of acemetacin.es
dc.identifier.citationChávez-Piña AE, Vong L, McKnight W, Dicay M, Zanardo RC, Ortiz MI, Castañeda-Hernández G, Wallace JL. Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol. 2008;155(6):857-64. ISSN:1476-5381.es
dc.identifier.urihttps://repository.uaeh.edu.mx/bitstream/handle/123456789/11893
dc.languageesen_US
dc.subjectFarmacología de la Reproducción y Analgesia inducida por neuroesteroides y AINESes
dc.titleLack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safetyes
dc.typeArticleen_US

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
lack.pdf
Tamaño:
202.15 KB
Formato:
Adobe Portable Document Format
Descargar

Colecciones

Artículos arbitrados